RAD51 and ovarian carcinoma: The homologous recombination REpair CAPacity (RECAP) test developed by Meijer et al. was first performed to assess the formation of RAD51 foci in proliferating cells (in S/G2-phase) following irradiation of fresh breast cancer samples as well as fresh primary ovarian cancer cells [61].